B. Riley Wealth Advisors’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-9,025
Closed -$273K 675
2016
Q2
$273K Buy
+9,025
New +$183K 0.05% 423

B. Riley Wealth Advisors's CPXX Position: Q3 2016 in Review

B. Riley Wealth Advisors sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 9,025 shares — an estimated $273K sold.

B. Riley Wealth Advisors first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $273K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • B. Riley Wealth Advisors reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 9,025 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $273K.
  • B. Riley Wealth Advisors first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • B. Riley Wealth Advisors's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $273K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.